Brief: Mabion Signs About 2 Mln Zloty Deal With WPD Pharmaceuticals
17/04/2025 17:12
April 17 (Reuters) - Mabion SA MABP.WA: SIGNS AGREEMENT WITH WPD PHARMACEUTICALS FOR ANALYTICAL METHOD DEVELOPMENT DEAL VALUE SET AT ABOUT PLN 2.0 MILLION NET Source text: ID:nEM8nr1RWa Further company coverage: MABP.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Signs Annex To Extend Production Agreement With Novavax To End of 2029
Brief: Mabion Signs Deal With Oddifact Sas On Preparing Mabioncd20 For FDA Consultation
Brief: Mabion Q1 Net Loss 9.7 Million Zlotys
Brief: Mabion Signs LoI With Oddifact On Use Of MabionCD20 Drug For Orphan Diseases
Brief: Mabion FY Net Loss 62.6 Million Zlotys